The JCVI presented its final recommendations on phase two of the vaccination program on 26 February, concluding that people between the ages of 40 and 49 would be the first to receive an invitation to vaccinate.

People between the ages of 30 and 39 and 18 to 29 will be the next guests, with the government aiming to have all adults vaccinated by the end of July, increasing the likelihood of outdoor events and holidays occurring in August.

Professor Wei Shen Lim, president of Kovid-19 for JCVI, said: “Vaccination prevents people from dying and the current strategy is to prioritize those who are likely to have serious consequences and die from Kovid-19.

“The evidence clearly shows that the risk of hospitalization and death increases with age.

“The vaccination program is a huge success and ongoing deployment based on age will provide the greatest benefit in the shortest possible time, including those in occupations at high risk of exposure.

Why is there a delay between the first and second jobs?

Regulators said the key to success would be to give as many people as the initial dose of the vaccine, in addition to giving two full doses in four to 12 weeks, which provides some protection against the virus.

One study found that single doses of the Oxford vaccine were 76% effective between 22 days and 90 days after injection, increasing to 82.4% after the second dose at this point. Researchers involved in the trial said the results supported the decision to increase the interval between the UK initial dose and the booster dose of the vaccine to 12 weeks.

One study found that a single dose of the Pfizer / BioNTech vaccine provided a “very high” level of protection against Kovid-19 after just 21 days without the need for a second “complementary” vaccination.

The UEA study, which has not yet been reviewed, looked at data from Israel where the vaccine was deployed. Scientists have found that the vaccine becomes 90% effective after 21 days – supporting Britain’s plans to delay the timing of a second vaccine.

Although it is not yet known how immunity persists for more than 21 days without a second dose, researchers believe it is “unlikely” to decline significantly over the next nine weeks.

Read more: efficacy, transmission compared to Oxford, Pfizer and other Kovid vaccines

How will I be invited to vaccinate?

When you are eligible for the vaccine, the NHS will contact you and ask you to make an appointment.

If you are registered with a general practitioner, your practice will contact you by phone, SMS, email or post to book to receive the vaccine at your local immunization center.

If you are not already registered with a practice, you can always register at the medical office, and it is advisable to ensure that your contact details are up-to-date to ensure there are no delays.

However, if you are over 70 years old and have not yet taken the vaccine, the government urges you to contact your GP.

Three ways of delivery

Health Secretary Matt Hancock said there would be “three methods of delivery” with hospitals and mass immunization centers offering pharmacists and general practitioners vaccines.

A total of 250 active hospital sites, 89 vaccination centers and about 1,200 local immunization sites – including primary care networks, community pharmacy sites, and mobile teams – have been set up to ensure that everyone has easy access to the immunization center , No matter where they live.

Sites across the country have been converted into vaccination centers and started vaccination from 25 January.

Some of these places include Excel in London, Villa Park in Birmingham, Etihad Tennis Center in Manchester and Epsom Downs Racecourse in Surrey.

Mr. Johnson promised that vaccines would be available to people within 10 miles of their homes. For very few rural areas, vaccines will be delivered to them via mobile teams.

With three modes of administration, vaccine minister Nadim Zahavi said that there was a possibility that the vaccine could be administered in the form of a pill.

Getting a single dose of the vaccine in pill form can help overcome deployment problems in some parts of the world, including Europe.